RESOLUTIONS OF THE ANNUAL GENERAL MEETING OF BIOHIT OYJ
BIOHIT OYJ STOCK EXCHANGE RELEASE ON 21 APRIL 2009 AT 10:30 AM
RESOLUTIONS OF THE ANNUAL GENERAL MEETING OF BIOHIT OYJ
The Annual General Meeting (AGM) of Biohit Oyj held on 20 April 2009 approved
the financial statements of the Biohit Group and the parent company, and
discharged the members of the Board of Directors and the president and CEO from
liability for the financial year 2008.
Distribution of dividends
In accordance with the proposal by the Board of Directors the AGM decided that
no dividends be paid for the financial year 2008, and that the profit of EUR
945,125.10 be transferred to the retained profit and loss account.
Members of the Board of Directors
The AGM decided that the number of members of the Board of Directors is six (6).
Furthermore, the AGM elected Professor Reijo Luostarinen, Professor Mikko
Salaspuro, Professor Osmo Suovaniemi, MSc (Engin.), MBA Kalle Kettunen, BSc
(Econ.) Jukka Ant-Wuorinen and MSc (Soc. Sc.) Eero Lehti as members of the Board
until the end of the next AGM.
Additionally, the AGM decided that the chairman of the Board of Directors would
be paid a monthly fee of EUR 1,550 and the ordinary members would be paid a
monthly fee of EUR 1,200.
Auditors
The AGM elected authorized public accountants Ernst & Young Oy as the company's
auditors, with APA Erkka Talvinko as the head auditor, until the end of the next
AGM.
All decisions of the AGM were made unanimously. The minutes of the AGM are
available for review by shareholders by 24 April 2009 at the company's website
www.biohit.com/investors and the corporate headquarters of Biohit; address
Laippatie 1, 00880 Helsinki.
Board of Directors of Biohit Oyj
Additional information:
Osmo Suovaniemi, M.D., Ph.D., Professor
President & CEO
Tel: +358-9-773 861
GSM: +358-40-745 5605
Email: osmo.suovaniemi@biohit.com
Distribution:
Helsinki Exchanges
Central storage facility
Press
www.biohit.com
About Biohit Oyj
Biohit Oyj develops, manufactures and markets liquid handling products and
diagnostic test systems for use in research, health care and industrial
laboratories.
Liquid handling products include electronic and mechanical pipettes and
dispensers, and disposable tips, as well as pipette maintenance and calibration
services. Diagnostics business comprises products and analysis systems for
diagnosing, screening and prevention of gastrointestinal diseases, e.g. the
blood-sample based GastroPanel and GastroView, for diagnosing diseases of the
stomach and associated risks, as well as quick tests for the diagnosis of
lactose intolerance, H. pylori infection and fecal occult blood.
Biohit Group employs 370 people in 8 countries. Biohit Oyj is headquartered in
Finland. Biohit has subsidiaries in France, Germany, the UK, Russia, China,
Japan and the USA. Additionally, Biohit's products are sold by approximately 450
distributors in 70 countries. Biohit's share (BIOBV) is quoted on NASDAQ OMX
Helsinki.
Read more at www.biohit.com